BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3570170)

  • 1. Treatment of Wilson's disease: in D-penicillamine we trust--what about zinc?
    Lipsky MA; Gollan JL
    Hepatology; 1987; 7(3):593-5. PubMed ID: 3570170
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Wilson's disease.
    Brewer GJ; Yuzbasiyan-Gurkan V; Young AB
    Semin Neurol; 1987 Jun; 7(2):209-20. PubMed ID: 3332455
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral zinc therapy for Wilson's disease.
    Nutr Rev; 1984 May; 42(5):184-6. PubMed ID: 6377131
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Wilson's disease.
    Deiss A
    Ann Intern Med; 1983 Sep; 99(3):398-400. PubMed ID: 6614689
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of Wilson's disease in paediatrics: oral zinc therapy versus penicillamine.
    Cossack ZT; Bouquet J
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 7():514-7. PubMed ID: 3776618
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration).
    Hoogenraad TU; Koevoet R; de Ruyter Korver EG
    Eur Neurol; 1979; 18(3):205-11. PubMed ID: 477692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wilson's disease: an update, with emphasis on new approaches to treatment.
    Brewer GJ; Yuzbasiyan-Gurkan V
    Dig Dis; 1989; 7(4):178-93. PubMed ID: 2663256
    [No Abstract]   [Full Text] [Related]  

  • 8. [Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu].
    Günther K; Siegemund R; Lössner J; Kühn HJ
    Radiobiol Radiother (Berl); 1988; 29(2):226-9. PubMed ID: 3399664
    [No Abstract]   [Full Text] [Related]  

  • 9. Deterioration of Wilson's disease following the start of penicillamine therapy.
    Pall HS; Williams AC; Blake DR
    Arch Neurol; 1989 Apr; 46(4):359-61. PubMed ID: 2705894
    [No Abstract]   [Full Text] [Related]  

  • 10. Penicillamine in Wilson's disease.
    Danks DM
    Lancet; 1982 Aug; 2(8295):435-6. PubMed ID: 6124819
    [No Abstract]   [Full Text] [Related]  

  • 11. The mechanisms of penicillamine, trientine, and zinc in the treatment of Wilson's disease.
    Yarze JC
    Am J Gastroenterol; 1995 Jun; 90(6):1026. PubMed ID: 7771405
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of Wilson's disease: penicillamine or triene?
    Kiechl SG; Willeit J; Aichner F; Felber S
    Acta Neurol Scand; 1992 Feb; 85(2):154-7. PubMed ID: 1574992
    [No Abstract]   [Full Text] [Related]  

  • 13. Two and half years of oral zinc sulphate therapy in an adult patient with Wilson's disease.
    Pasqualicchio M; Milanino R; Marrella M; Moretti U; Tomelleri G; Velo GP
    Pharmacol Res; 1989; 21 Suppl 1():151-2. PubMed ID: 2633173
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative metabolism of copper and zinc in patients with Wilson's disease (hepatolenticular degeneration).
    McCall JT; Goldstein NP; Randall RV; Gross JB
    Am J Med Sci; 1967 Jul; 254(1):13-23. PubMed ID: 6027683
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Wilson's disease with zinc. 5 cases].
    Bona I; Broussolle E; Neuschwander P; Confavreux C; Fontanges T; Accominotti M; Chazot G
    Rev Neurol (Paris); 1993; 149(6-7):393-7. PubMed ID: 8303158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
    Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV
    Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484
    [No Abstract]   [Full Text] [Related]  

  • 17. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
    Ramadori G; Keidl E; Hütteroth T; Dormeyer HH; Manns M; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1985 Jan; 23(1):25-9. PubMed ID: 4060799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Drug Managements of Wilson's Disease: From West to East.
    Li WJ; Chen C; You ZF; Yang RM; Wang XP
    Curr Neuropharmacol; 2016; 14(4):322-5. PubMed ID: 26639459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical considerations for an effective medical therapy in Wilson's disease.
    Weiss KH; Stremmel W
    Ann N Y Acad Sci; 2014 May; 1315():81-5. PubMed ID: 24754532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.